Skip to main content

Advertisement

SpringerLink
Log in

RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224

  • Research Article
  • Published:
Tumor Biology

Abstract

The purposes of this study were to determine the expression profile of Raf kinase inhibitor protein (RKIP) in human gastric cancer cells and its effect on the biological characteristics of SGC-7901 cell lines, to examine the modulatory effect of microRNA-224 (miR-224) on RKIP. The research will provide novel strategies for gastric cancer treatment in the future. Quantitative real-time reverse transcription PCR (qRT-PCR) was employed to determine the expression profile of RKIP in gastric cancer cell lines (SGC-7901, MGC80-3, and MKN45). A eukaryotic expression vector, pcDNA3.1-RKIP, was constructed and transfected into SGC-7901 cells. Changes in RKIP protein expression were examined by Western blot assays, and the effect of RKIP overexpression on SCG-7901 cell viability was determined by 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-diphenytetrazoliumromide (MTT) assays. The effect of RKIP overexpression on SGC-7901 cell proliferation and apoptosis was analyzed by flow cytometry and that on the migration of SGC-7901 cells was investigated by Transwell migration assays. RKIP was identified to be a regulatory target gene of miR-224 using a luciferase reporter gene system, and the effect of miR-224 on intracellular RKIP protein expression was examined by Western blot assays. The regulatory effect of miR-224 on the biological characteristics of RKIP was investigated by MTT, flow cytometry, and Transwell invasion chamber assays. The expression of RKIP in gastric cancer cells was decreased significantly in comparison to that of normal gastric mucosal epithelial cells (GES-1) (p < 0.01), as demonstrated by qRT-PCR assays. Compared with the control group, the up-regulation of RKIP intracellular expression was observed in SGC-7901 cells after transfection of pcDNA3.1-RKIP for 48 h (p < 0.01). There were significant decreases in cell viability and the S-phase fraction (p < 0.05), concomitant with a significant increase in apoptosis (p < 0.01), as well as a significant reduction in cells migrating through Transwell chambers (p < 0.05), as shown by MTT, flow cytometry, and Transwell invasion chamber assays. A significant decrease in luciferase activities in cells transfected with a miR-224 mimic was observed compared with that of the control group (p < 0.05), as suggested by the luciferase reporter gene system. As shown by Western blot assays, there was a significant decrease in RKIP expression in SGC-7901 cells transfected with the miR-224 mimic for 48 h compared with the control group (p < 0.05). As shown by MTT, flow cytometry, and Transwell invasion chamber assays, the changes in biological characteristics induced by RKIP overexpression could be suppressed in SGC-7901 cells after transfection of the miR-224 mimic. In conclusion, the down-regulation of RKIP expression was observed in human gastric cell lines, and miR-224 could negatively regulate the expression and biological characteristics of RKIP, contributing to suppress the proliferation and invasion of gastric cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251–61.

    PubMed Central  PubMed  Google Scholar 

  2. Bu Z, Ji J. Controversies in the diagnosis and management of early gastric cancer. Chin J Cancer Res. 2013;25(3):263–6.

    PubMed Central  PubMed  Google Scholar 

  3. Ryu KW, SENORITA Study Group. Future perspective of laparoscopic surgery for gastric cancer: sentinel node navigation function-preserving surgery for early gastric cancer. Transl Gastrointest Cancer. 2013;2(3):160–3.

    Google Scholar 

  4. Ling TC, Kang JI, Slater JD, Yang GY. Proton therapy for gastrointestinal cancers. Transl Cancer Res. 2012;1(3):150–8.

    Google Scholar 

  5. Wang YX, Wang DW, Zhu XM, Zhao F, Leung KC. Carbon coated superparamagnetic iron oxide nanoparticles for sentinel lymph nodes mapping. Quant Imaging Med Surg. 2012;2:53–6.

    PubMed Central  PubMed  Google Scholar 

  6. Smith HS. Painful boney metastases. Ann Palliat Med. 2012;1(1):14–31.

    PubMed  Google Scholar 

  7. Kang B, Sun XH. Regulation of cancer stem cells by RING finger ubiquitin ligases. Stem Cell Investig. 2014;1:5.

    Google Scholar 

  8. Gotoda T, Kusano C, Moriyasu F. Future perspective of gastric cancer endotherapy. Ann Transl Med. 2014;2(3):25.

    PubMed Central  PubMed  Google Scholar 

  9. Achyut BR, Yang L. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141(4):1167–78.

    Article  CAS  PubMed  Google Scholar 

  10. St Hill CA. Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci. 2011;17:3233–51.

    Article  Google Scholar 

  11. Ali AS, Ahmad A, Ali S, Bao B, Philip PA, Sarkar FH. The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis. J Cell Physiol. 2013;228(1):36-42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Yamada Y. Molecular therapy for gastric cancer. Chin Clin Oncol. 2013;2(1):5.

    PubMed  Google Scholar 

  13. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249–58.

    Article  CAS  PubMed  Google Scholar 

  14. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4(3):279–94.

    Article  CAS  PubMed  Google Scholar 

  15. Li JH, Zhang SW, Liu J, Shao MZ, Chen L. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J (Engl). 2012;125(8):1479–95.

    Google Scholar 

  16. Bijelic L, Sugarbaker PH. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. Ann Ital Chir. 2012;83(3):224–31.

    PubMed  Google Scholar 

  17. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401(6749):173–7.

    Article  CAS  PubMed  Google Scholar 

  18. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets. 2008;12(10):1275–87.

    Article  CAS  PubMed  Google Scholar 

  19. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008;18(4):452–7.

    Article  CAS  PubMed  Google Scholar 

  20. Khamis ZI, Iczkowski KA, Sang QX. Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev. 2012;32(5):1026–77.

    Article  CAS  PubMed  Google Scholar 

  21. Morecroft I, Doyle B, Nilsen M, Kolch W, Mair K, Maclean MR. Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension. Br J Pharmacol. 2011;163(5):948–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 2010;299(2):137–49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878–89.

    Article  CAS  PubMed  Google Scholar 

  24. Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol. 2010;53(5):872–9.

    Article  CAS  PubMed  Google Scholar 

  25. Lin K, Baritaki S, Militello L, Malaponte G, Bevelacqua Y, Bonavida B. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. Genes Cancer. 2010;1(5):409–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Al-Mulla F, Hagan S, Al-Ali W, Jacob SP, Behbehani AI, Bitar MS, et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol. 2008;61(4):524–9.

    Article  CAS  PubMed  Google Scholar 

  27. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res. 2009;7(6):832–40.

    Article  CAS  PubMed  Google Scholar 

  28. Minn AJ, Bevilacqua E, Yun J, Rosner MR. Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle. 2012;11(13):2452–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Bonavida B, Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry. Crit Rev Oncog. 2011;16(3–4):211–26.

    Article  PubMed  Google Scholar 

  30. Cheng J, Fan XM. Role of cyclooxygenase-2 in gastric cancer development and progression. World J Gastroenterol. 2013;19(42):7361–8.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Nakamura S, Matsumoto T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. World J Gastroenterol. 2013;19(45):8181–7.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget. 2013;4(12):2171–85.

    PubMed Central  PubMed  Google Scholar 

  33. He C, Chen M, Liu J, Yuan Y. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res. 2014;759:14-26.

    Article  CAS  PubMed  Google Scholar 

  34. Al-Mulla F, Bitar MS, Taqi Z, Yeung KC. RKIP: much more than Raf kinase inhibitory protein. J Cell Physiol. 2013;228(8):1688–702.

    Article  CAS  PubMed  Google Scholar 

  35. Escara-Wilke J, Yeung K, Keller ET. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012;31(3–4):615–20.

    Article  CAS  PubMed  Google Scholar 

  36. Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30(3):255–67.

    Article  PubMed  Google Scholar 

  37. Wang X, Cao L, Wang Y, Liu N, You Y. Regulation of let-7 and its target oncogenes (review). Oncol Lett. 2012;3(5):955–60.

    PubMed Central  CAS  PubMed  Google Scholar 

  38. Zhou X, Yuan P, He Y. Role of microRNAs in peripheral artery disease (review). Mol Med Rep. 2012;6(4):695-700.

    CAS  PubMed  Google Scholar 

  39. Ui-Tei K, Nishi K, Takahashi T, Nagasawa T. Thermodynamic control of small RNA-mediated gene silencing. Front Genet. 2012;3:101.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Yang JS, Maurin T, Lai EC. Functional parameters of Dicer-independent microRNA biogenesis. RNA. 2012;18(5):945–57.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9(6).

  42. Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther. 2012;12(9):1221-39.

    Article  CAS  PubMed  Google Scholar 

  43. Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H, et al. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol. 2012;18(22):2745–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank editors from the American Journal Experts (AJE) company who edited this manuscript.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, General Hospital of Chinese People’s Liberation Army, No. 28, Fuxing Rd, 100853, Beijing, China

    Hongyi Liu, Peng Li, Bing Li, Peng Sun, Jiajin Zhang, Baishi Wang & Baoqing Jia

Authors
  1. Hongyi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiajin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Baishi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Baoqing Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baoqing Jia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, H., Li, P., Li, B. et al. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224. Tumor Biol. 35, 10095–10103 (2014). https://doi.org/10.1007/s13277-014-2303-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2303-4

Keywords

Search

Navigation